$JNJ Headlines J&J to buy Alios BioPharma for
Post# of 88933
Posted On: 10/06/2014 11:44:06 AM
$JNJ Headlines
J&J to buy Alios BioPharma for $1.75 billion 9:23 a.m. Sept. 30, 2014 - Tess Stynes
Inovio, GeneOne to move Ebola vaccine to human trials 11:42 a.m. Sept. 24, 2014 - Erin McCarthy
Dow industrials take flight, rally to uncharted territory 10:31 a.m. Sept. 19, 2014 - Michael Ashbaugh
7 reasons to be bullish on Microsoft 6:00 a.m. Sept. 18, 2014 - Jeff Reeves
5 pretty amazing facts about Alibaba 9:54 a.m. Sept. 15, 2014 - Tim Mullaney
Here’s what history says about the stock market in September 5:39 a.m. Sept. 2, 2014 - Mark Hulbert
This one stock sector can withstand all the ‘bubble’ talk 6:00 a.m. Aug. 21, 2014 - Jeff Reeves
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
You don’t have to be a mega-mind to get this trade right 7:54 a.m. Aug. 6, 2014 - Jim Lowell
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
These eight health-care stocks could rise up to 75% 1:48 p.m. Aug. 5, 2014 - Philip van Doorn
J&J to call for voluntary return of morcellators 5:30 p.m. July 30, 2014 - MarketWatch.com
Chipotle tops S&P 500, Herbalife ignores ‘death blow’ 1:14 p.m. July 22, 2014 - MarketWatch
Johnson & Johnson sets $5 billion share buyback 5:20 p.m. July 21, 2014 - Jim Jelter
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook 10:55 a.m. July 15, 2014 - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. July 15, 2014 - Angela Johnson
Newscast: NBA wants to double TV fees 9:59 a.m. July 15, 2014 - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. July 15, 2014 - MarketWatch.com
Should A Dividend Growth Investor Even Consider A Company Like Seadrill? 9:47 a.m. Today - Seeking Alpha
Corrections & Amplifications 9:32 p.m. Oct. 3, 2014 - The Wall Street Journal Interactive Edition
Health Care, Tech Names Offer Dividend Growth, Stability 5:29 p.m. Oct. 3, 2014 - Investors Business Daily
The Question Isn't If Gilead's Hep C Combo Will Be Approved In The US By Next Friday; The Question Is The Price Of The Regimen 12:12 p.m. Oct. 3, 2014 - Seeking Alpha
Roche Presents Data on Cancer Immunotherapy Candidate - Analyst Blog 9:50 a.m. Oct. 3, 2014 - Zacks.com
Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma 9:41 a.m. Oct. 3, 2014 - TheStreet.com
Will Gilead Sciences Score Healthy Gains For Investors? 12:03 p.m. Oct. 2, 2014 - Investors Business Daily
High-Yield Portfolio Still Yielding 8% After 18 Months 11:00 a.m. Oct. 2, 2014 - Seeking Alpha
GeoVax jumps on the Ebola bandwagon 10:35 a.m. Oct. 2, 2014 - Seeking Alpha
Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst 8:02 a.m. Oct. 2, 2014 - 247WallSt.com
Sure Bets: Slow-Changing Industries for Long-Term Investors 5:48 p.m. Oct. 1, 2014 - GuruFocus.com
AbbVie Announces Positive Results on Oncology Candidate - Analyst Blog 4:30 p.m. Oct. 1, 2014 - Zacks.com
Johnson & Johnson Falls On Bernstein Downgrade 2:09 p.m. Oct. 1, 2014 - benzinga.com
Why Gilead Sciences (GILD) Stock Is Declining Today 1:07 p.m. Oct. 1, 2014 - TheStreet.com
Bayer closes acquisition of consumer care business of Merck & Co., Inc. for USD 14.2 billion 12:58 p.m. Oct. 1, 2014 - CNW Group
FDA publishes guidance on med device cybersecurity 10:05 a.m. Oct. 1, 2014 - Seeking Alpha
Abbott Labs Completes CFR Pharmaceuticals Acquisition - Analyst Blog 9:50 a.m. Oct. 1, 2014 - Zacks.com
Why Johnson & Johnson (JNJ) Stock Is Lower Today 9:36 a.m. Oct. 1, 2014 - TheStreet.com
Bernstein Downgrades Johnson & Johnson To Market Perform, Shares Drop 7:13 a.m. Oct. 1, 2014 - benzinga.com
Buy ‘Aristocrat’ Funds for the Quality, Not the Dividend Yield 4:32 a.m. Oct. 1, 2014 - InvestorPlace.com
Physicians Value Long-acting and FDC Antidiabetic Agents, Although Competitive Pricing Will Be Needed for Favorable Reimbursement 11:00 a.m. Oct. 1, 2014 - PR Newswire - PRF
Legal Settlement, Data Presentation, Welfare Initiatives, Acquisition Talks, and Study Results - Research Reports on Shire, Merck, Medtronic, Salix and Johnson & Johnson 9:10 a.m. Oct. 1, 2014 - PR Newswire - PRF
Defective Surgical Product Lawsuits Filed Against Johnson & Johnson 2:21 p.m. Sept. 30, 2014 - BusinessWire - BZX
Alios BioPharma Announces Acquisition Agreement With Johnson & Johnson 8:30 a.m. Sept. 30, 2014 - Marketwire
Johnson & Johnson Announces Agreement To Acquire Alios BioPharma 8:30 a.m. Sept. 30, 2014 - PR Newswire - PRF
The Spooky Truth: What You Need To Know About Contact Lens Hygiene 7:17 a.m. Sept. 30, 2014 - PR Newswire - PRF
Pharma Stocks Review - AbbVie, Merck, Johnson and Johnson, GlaxoSmithKline, and Bristol-Myers Squibb 9:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Latin America Home Healthcare Market (By Device Types: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies; By Services...) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 20 5:02 p.m. Sept. 24, 2014 - PR Newswire - PRF
In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020 3:46 p.m. Sept. 24, 2014 - PR Newswire - PRF
The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies 5:40 p.m. Sept. 23, 2014 - PR Newswire - PRF
Wearable Technology Market Report 2014-2019 4:15 p.m. Sept. 23, 2014 - PR Newswire - PRF
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results 2:00 p.m. Sept. 23, 2014 - PR Newswire - PRF
Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien 9:05 a.m. Sept. 23, 2014 - PR Newswire - PRF
OxySure Systems Selected for USPTO / Smithsonian Innovation Expo 8:02 a.m. Sept. 23, 2014 - ACCESSWIRE
Twenty Employers to Attend Annual Life Science Hiring Event Next Week 9:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Mr. David Guerette Joins Matamec's Board of Directors 3:01 p.m. Sept. 19, 2014 - Marketwire
New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma 9:15 a.m. Sept. 15, 2014 - PR Newswire - PRF
Sirius Solutions names Jessica Harris Director of Supply Chain Practice - Dallas/Ft. Worth Office 10:52 a.m. Sept. 12, 2014 - PR Newswire - PRF
Facial Care Market - Asia-Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019 8:48 p.m. Sept. 10, 2014 - PR Newswire - PRF
Transvaginal Mesh Lawsuit Latest Update News: J&J's Ethicon Loses another Mesh Trial 5:00 a.m. Sept. 9, 2014 - PR Newswire - PRF
J&J to buy Alios BioPharma for $1.75 billion 9:23 a.m. Sept. 30, 2014 - Tess Stynes
Inovio, GeneOne to move Ebola vaccine to human trials 11:42 a.m. Sept. 24, 2014 - Erin McCarthy
Dow industrials take flight, rally to uncharted territory 10:31 a.m. Sept. 19, 2014 - Michael Ashbaugh
7 reasons to be bullish on Microsoft 6:00 a.m. Sept. 18, 2014 - Jeff Reeves
5 pretty amazing facts about Alibaba 9:54 a.m. Sept. 15, 2014 - Tim Mullaney
Here’s what history says about the stock market in September 5:39 a.m. Sept. 2, 2014 - Mark Hulbert
This one stock sector can withstand all the ‘bubble’ talk 6:00 a.m. Aug. 21, 2014 - Jeff Reeves
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
You don’t have to be a mega-mind to get this trade right 7:54 a.m. Aug. 6, 2014 - Jim Lowell
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
These eight health-care stocks could rise up to 75% 1:48 p.m. Aug. 5, 2014 - Philip van Doorn
J&J to call for voluntary return of morcellators 5:30 p.m. July 30, 2014 - MarketWatch.com
Chipotle tops S&P 500, Herbalife ignores ‘death blow’ 1:14 p.m. July 22, 2014 - MarketWatch
Johnson & Johnson sets $5 billion share buyback 5:20 p.m. July 21, 2014 - Jim Jelter
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook 10:55 a.m. July 15, 2014 - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. July 15, 2014 - Angela Johnson
Newscast: NBA wants to double TV fees 9:59 a.m. July 15, 2014 - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. July 15, 2014 - MarketWatch.com
Should A Dividend Growth Investor Even Consider A Company Like Seadrill? 9:47 a.m. Today - Seeking Alpha
Corrections & Amplifications 9:32 p.m. Oct. 3, 2014 - The Wall Street Journal Interactive Edition
Health Care, Tech Names Offer Dividend Growth, Stability 5:29 p.m. Oct. 3, 2014 - Investors Business Daily
The Question Isn't If Gilead's Hep C Combo Will Be Approved In The US By Next Friday; The Question Is The Price Of The Regimen 12:12 p.m. Oct. 3, 2014 - Seeking Alpha
Roche Presents Data on Cancer Immunotherapy Candidate - Analyst Blog 9:50 a.m. Oct. 3, 2014 - Zacks.com
Biotech Stock Mailbag: Seattle Genetics, Achillion, Catalyst Pharma 9:41 a.m. Oct. 3, 2014 - TheStreet.com
Will Gilead Sciences Score Healthy Gains For Investors? 12:03 p.m. Oct. 2, 2014 - Investors Business Daily
High-Yield Portfolio Still Yielding 8% After 18 Months 11:00 a.m. Oct. 2, 2014 - Seeking Alpha
GeoVax jumps on the Ebola bandwagon 10:35 a.m. Oct. 2, 2014 - Seeking Alpha
Makers of the 10 Top-Selling Cancer Drugs Catch the Eye of Analyst 8:02 a.m. Oct. 2, 2014 - 247WallSt.com
Sure Bets: Slow-Changing Industries for Long-Term Investors 5:48 p.m. Oct. 1, 2014 - GuruFocus.com
AbbVie Announces Positive Results on Oncology Candidate - Analyst Blog 4:30 p.m. Oct. 1, 2014 - Zacks.com
Johnson & Johnson Falls On Bernstein Downgrade 2:09 p.m. Oct. 1, 2014 - benzinga.com
Why Gilead Sciences (GILD) Stock Is Declining Today 1:07 p.m. Oct. 1, 2014 - TheStreet.com
Bayer closes acquisition of consumer care business of Merck & Co., Inc. for USD 14.2 billion 12:58 p.m. Oct. 1, 2014 - CNW Group
FDA publishes guidance on med device cybersecurity 10:05 a.m. Oct. 1, 2014 - Seeking Alpha
Abbott Labs Completes CFR Pharmaceuticals Acquisition - Analyst Blog 9:50 a.m. Oct. 1, 2014 - Zacks.com
Why Johnson & Johnson (JNJ) Stock Is Lower Today 9:36 a.m. Oct. 1, 2014 - TheStreet.com
Bernstein Downgrades Johnson & Johnson To Market Perform, Shares Drop 7:13 a.m. Oct. 1, 2014 - benzinga.com
Buy ‘Aristocrat’ Funds for the Quality, Not the Dividend Yield 4:32 a.m. Oct. 1, 2014 - InvestorPlace.com
Physicians Value Long-acting and FDC Antidiabetic Agents, Although Competitive Pricing Will Be Needed for Favorable Reimbursement 11:00 a.m. Oct. 1, 2014 - PR Newswire - PRF
Legal Settlement, Data Presentation, Welfare Initiatives, Acquisition Talks, and Study Results - Research Reports on Shire, Merck, Medtronic, Salix and Johnson & Johnson 9:10 a.m. Oct. 1, 2014 - PR Newswire - PRF
Defective Surgical Product Lawsuits Filed Against Johnson & Johnson 2:21 p.m. Sept. 30, 2014 - BusinessWire - BZX
Alios BioPharma Announces Acquisition Agreement With Johnson & Johnson 8:30 a.m. Sept. 30, 2014 - Marketwire
Johnson & Johnson Announces Agreement To Acquire Alios BioPharma 8:30 a.m. Sept. 30, 2014 - PR Newswire - PRF
The Spooky Truth: What You Need To Know About Contact Lens Hygiene 7:17 a.m. Sept. 30, 2014 - PR Newswire - PRF
Pharma Stocks Review - AbbVie, Merck, Johnson and Johnson, GlaxoSmithKline, and Bristol-Myers Squibb 9:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Latin America Home Healthcare Market (By Device Types: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies; By Services...) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 20 5:02 p.m. Sept. 24, 2014 - PR Newswire - PRF
In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020 3:46 p.m. Sept. 24, 2014 - PR Newswire - PRF
The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies 5:40 p.m. Sept. 23, 2014 - PR Newswire - PRF
Wearable Technology Market Report 2014-2019 4:15 p.m. Sept. 23, 2014 - PR Newswire - PRF
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results 2:00 p.m. Sept. 23, 2014 - PR Newswire - PRF
Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien 9:05 a.m. Sept. 23, 2014 - PR Newswire - PRF
OxySure Systems Selected for USPTO / Smithsonian Innovation Expo 8:02 a.m. Sept. 23, 2014 - ACCESSWIRE
Twenty Employers to Attend Annual Life Science Hiring Event Next Week 9:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Mr. David Guerette Joins Matamec's Board of Directors 3:01 p.m. Sept. 19, 2014 - Marketwire
New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma 9:15 a.m. Sept. 15, 2014 - PR Newswire - PRF
Sirius Solutions names Jessica Harris Director of Supply Chain Practice - Dallas/Ft. Worth Office 10:52 a.m. Sept. 12, 2014 - PR Newswire - PRF
Facial Care Market - Asia-Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019 8:48 p.m. Sept. 10, 2014 - PR Newswire - PRF
Transvaginal Mesh Lawsuit Latest Update News: J&J's Ethicon Loses another Mesh Trial 5:00 a.m. Sept. 9, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼